Literature DB >> 9924648

Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

C P Ferguson1, M C La Via, P J Crossan, W H Kaye.   

Abstract

OBJECTIVE: Recent data suggest that serotonin selective reuptake inhibiter (SSRI) medication is useful in preventing relapse in weight-restored anorexics. Our clinical impression has been that SSRIs are not effective in patients who are underweight with anorexia nervosa.
METHOD: In order to determine whether there was any benefit for SSRI medication in underweight anorexics, we compared two groups of underweight anorexics upon admission to our inpatient hospital using a retrospective chart review.
RESULTS: Sixty percent of anorexic patients were taking an SSRI upon admission to our inpatient hospital. The 24 subjects taking an SSRI were compared to the 16 subjects not taking an SSRI. These two groups had similar ages and body weights as well as scores for measures of anxiety and depression and most core eating disorder symptoms. DISCUSSION: These results suggest that SSRI medication had no effect on clinical symptoms of malnourished underweight anorexics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9924648     DOI: 10.1002/(sici)1098-108x(199901)25:1<11::aid-eat2>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  12 in total

Review 1.  Eating disorders in children and adolescents: epidemiology, diagnosis and treatment.

Authors:  M Kohn; N H Golden
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

3.  Activity-based anorexia has differential effects on apical dendritic branching in dorsal and ventral hippocampal CA1.

Authors:  Tara G Chowdhury; Nicole C Barbarich-Marsteller; Thomas E Chan; Chiye Aoki
Journal:  Brain Struct Funct       Date:  2014-11       Impact factor: 3.270

Review 4.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

5.  Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.

Authors:  Vikas Duvvuri; Taya Cromley; Megan Klabunde; Kerri Boutelle; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-02-22       Impact factor: 4.861

6.  Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.

Authors:  Stephanie J Klenotich; Mariel P Seiglie; Matthew S McMurray; Jamie D Roitman; Daniel Le Grange; Priya Dugad; Stephanie C Dulawa
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

Review 7.  [Serotonin reuptake inhibitors in children. Warnings on the administration, results analysis, and recommendations].

Authors:  J M Fegert; B Herpertz-Dahlmann
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

Review 8.  The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.

Authors:  G Abbate Daga; L Gianotti; V Mondelli; R Quartesan; S Fassino
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

9.  Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats.

Authors:  Hiske M van der Stelt; Laus M Broersen; Berend Olivier; Herman G M Westenberg
Journal:  Psychopharmacology (Berl)       Date:  2003-11-25       Impact factor: 4.530

10.  Current and emerging directions in the treatment of eating disorders.

Authors:  Tiffany A Brown; Pamela K Keel
Journal:  Subst Abuse       Date:  2012-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.